AstraZeneca faces olaparib questions
June 24, 2014Manufacturing and Production, Research and Development, Sales and Marketing AstraZeneca, Cancer, FDA, olaparib, ovarian
AstraZeneca is facing questions from US regulators over the efficacy of one of its most promising late-stage treatments. Olaparib is …
Lilly launches online board game
June 24, 2014Medical Communications, Sales and Marketing Boehringer, Gamification, Syrum, destination discovery, lillypad
Eli Lilly has created an online board game called ‘Destination Discovery’ that it says can help users enjoy the challenges …
Bayer enters $252 million Dimension deal
June 24, 2014Manufacturing and Production, Research and Development, Sales and Marketing Bayer, dimension, haemophilia, haemophilia a, therapeutics
Bayer HealthCare will pay up to $252 million to Dimension Therapeutics in a deal which sees the companies collaborate on …
Cello Health Insight promotes two
June 24, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cello, cello health insight, itani
Healthcare research agency Cello Health Insight has made two director level appointments from within to manage a training programme. Leyla …
Roche to launch new MS collaboration
June 23, 2014Research and Development, Sales and Marketing MS, Roche, inception sciences, multiple sclerosis, versant ventures
Roche has launched a new research collaboration to investigate ways of reversing the debilitating nerve damage caused by multiple sclerosis …
Novartis back under microscope
June 23, 2014Medical Communications, Sales and Marketing Italy, Novartis, avastin, fraud, influenza, vaccines
Novartis is under the microscope yet again in Italy, with police visiting the company’s sites at Siena and Origgio in …
Life Sciences Hub Wales – new COO and
 board


June 23, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Life Sciences Hub Wales, Wales, ian barwick
Dr Ian Barwick has been appointed chief operating officer for Life Sciences Hub Wales along with several new board members.
 …
£100 million funding stream aids UK biotech
June 23, 2014Research and Development, Sales and Marketing BIA, Steve Bates, biomedical catalyst, funding
UK biotech companies are developing new therapies for cancer, Parkinson’s, diabetes and tinnitus as a direct result of the £100 …
Drug prices defy gravity – until patent expiry
June 23, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing John LaMattina, LaMattina, Pfizer, drug, pharma, pricing, research
How drugs are priced is a hot topic these days, and a new Bloomberg article will cause it to heat-up …
Conversis Medical hires global director
June 23, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing conversis, hooper, medical
Medical translation agency Conversis Medical has appointed Dr Mark Hooper as its global director. Hooper has worked in the pharma …
Boehringer abandons hep C
June 23, 2014Research and Development, Sales and Marketing AbbVie, Boehringer, HCV, faldaprevir, german, hep C
Boehringer Ingelheim has abandoned its hepatitis C (HCV) drug development programme as a dead loss after ‘re-evaluating’ its strategy. The …
Lilly’s Efient tipped for expanded NICE approval
June 20, 2014Sales and Marketing Effient, Efient, FDA, NHS, blood, lilly, longston, thinner
Eli Lilly’s anti-platelet drug Efient has been given the nod by UK healthcare watchdog NICE for more widespread use, pending …
Dr Reddy’s recalls blood pressure drug
June 20, 2014Manufacturing and Production Dr Reddy's, India, blood pressure, metoprolol succinate, recall, toprol
Indian generics manufacturer Dr Reddy’s Laboratories is in the midst of recalling more than 13,000 bottles of blood pressure medicine …
PAN expands creative team with two hires
June 20, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Ogilvy, Pan
Creative agency PAN has increased its team by hiring two new people in Minas Maroudas (pictured) who joins as senior …
Dementia research ‘achingly slow’
June 20, 2014Research and Development, Sales and Marketing Alzheimer's, Cameron, Parkinson's, Parkinsons, UK, billings, dementia, research
The UK prime minister’s envoy on dementia has described progress on research into the neurodegenerative condition as ‘achingly slow’. Global …
AbbVie moves in on Shire with $46 billion bid
June 20, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AbbVie, Abbott, AstraZeneca, Pfizer, Shire, merger
AbbVie is looking to acquire Ireland-based speciality biopharma firm Shire in a deal that could shore up the US company’s …
Novartis emphasises pharma growth
June 19, 2014Sales and Marketing Novartis, breezhaler, dermatology, heart failure, oncology, respiratory
Novartis is to grow its pharma business by focussing on five key areas and predicts that it will have 14 …
Teva chairman stepping down amid revamp
June 19, 2014Manufacturing and Production, Medical Communications, Sales and Marketing Frost, Levin, Teva, chief, generics, israel, pharma
Having just announced closing half of its manufacturing sites Teva has now confirmed that chairman Dr Phillip Frost is to …
Valeant goes hostile over Allergan hunt
June 19, 2014Sales and Marketing Allergan, Botox, Valeant, hostile, takeover
Valeant Pharmaceuticals has turned hostile in its bid to acquire Botox maker Allergan by employing strong-arm tactics in an attempt …
£16m dementia research platform launched
June 19, 2014Research and Development, Sales and Marketing Alzheimer's, MRC, Parkinson's, brain, dementia, ukdp
The Medical Research Council (MRC) has launched the UK Dementias Research Platform (UKDP), a £16 million public-private partnership set up …
Latest content
Pharma sees climate disruption as growing supply-chain risk
Manchester NHS-MHRA partnership to test new technologies in real-world care
